145020.KQ
Hugel, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 240,500.00
−2.04%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- KRW 2.7K
- Revenue estimate
- KRW 133.0B
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- KRW 3.0K
- EPS estimate
- KRW 3.0K
- Revenue actual
- KRW 125.7B
- Revenue estimate
- KRW 127.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026